Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

Michal J. Tracz, Kostandinos Sideras, Enrique R. Boloña, Rudy M. Haddad, Cassie Kennedy, Maria V. Uraga, Sean M. Caples, Patricia J. Erwin, Victor Manuel Montori

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Context: Androgen-deficient men are at increased risk of osteoporosis. The extent to which testosterone can prevent and treat osteoporosis in men remains unclear. Objective and Design: We performed a systematic review and meta-analysis of randomized placebo-controlled trials in men to estimate the effect of testosterone use on bone health outcomes. Data Sources: The review encompassed librarian-designed search strategies using MEDLINE (1966 to March 2005), EMBASE (1988 to March 2005), and Cochrane CENTRAL (inception to March 2005); a review of reference lists from included studies; and content expert files. Data Collection: Independently and in duplicate, we assessed the methodological quality of the eligible trials and collected data on bone mineral density and bone fractures at the longest point of complete follow-up. Data Synthesis: We included eight trials enrolling 365 patients. Two trials followed patients for more than 1 yr. Meta-analysis of these trials showed that, compared with placebo, im testosterone was associated with an 8% (95% confidence interval, 4%, 13%) gain in lumbar bone mineral density and transdermal testosterone had no significant impact. Testosterone use was associated with a nonsignificant 4% (95% confidence interval, -2%, 9%) gain in femoral neck bone mineral density with unexplained differences in results across trials (26% of these differences were not explained by chance alone). No trials measured or reported the effect of testosterone on fractures. Conclusions: Intramuscular testosterone moderately increased lumbar bone density in men; the results on femoral neck bone density are inconclusive. Without bone fracture data, the available trials offer weak and indirect inferences about the clinical efficacy of testosterone on osteoporosis prevention and treatment in men.

Original languageEnglish (US)
Pages (from-to)2011-2016
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Testosterone
Meta-Analysis
Bone
Randomized Controlled Trials
Placebos
Health
Bone and Bones
Bone Density
Osteoporosis
Minerals
Femur Neck
Bone Fractures
Confidence Intervals
Librarians
Information Storage and Retrieval
MEDLINE
Androgens

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. / Tracz, Michal J.; Sideras, Kostandinos; Boloña, Enrique R.; Haddad, Rudy M.; Kennedy, Cassie; Uraga, Maria V.; Caples, Sean M.; Erwin, Patricia J.; Montori, Victor Manuel.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 91, No. 6, 2006, p. 2011-2016.

Research output: Contribution to journalArticle

Tracz, Michal J. ; Sideras, Kostandinos ; Boloña, Enrique R. ; Haddad, Rudy M. ; Kennedy, Cassie ; Uraga, Maria V. ; Caples, Sean M. ; Erwin, Patricia J. ; Montori, Victor Manuel. / Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. In: Journal of Clinical Endocrinology and Metabolism. 2006 ; Vol. 91, No. 6. pp. 2011-2016.
@article{4bf13971fa16472c907484a08f813e31,
title = "Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials",
abstract = "Context: Androgen-deficient men are at increased risk of osteoporosis. The extent to which testosterone can prevent and treat osteoporosis in men remains unclear. Objective and Design: We performed a systematic review and meta-analysis of randomized placebo-controlled trials in men to estimate the effect of testosterone use on bone health outcomes. Data Sources: The review encompassed librarian-designed search strategies using MEDLINE (1966 to March 2005), EMBASE (1988 to March 2005), and Cochrane CENTRAL (inception to March 2005); a review of reference lists from included studies; and content expert files. Data Collection: Independently and in duplicate, we assessed the methodological quality of the eligible trials and collected data on bone mineral density and bone fractures at the longest point of complete follow-up. Data Synthesis: We included eight trials enrolling 365 patients. Two trials followed patients for more than 1 yr. Meta-analysis of these trials showed that, compared with placebo, im testosterone was associated with an 8{\%} (95{\%} confidence interval, 4{\%}, 13{\%}) gain in lumbar bone mineral density and transdermal testosterone had no significant impact. Testosterone use was associated with a nonsignificant 4{\%} (95{\%} confidence interval, -2{\%}, 9{\%}) gain in femoral neck bone mineral density with unexplained differences in results across trials (26{\%} of these differences were not explained by chance alone). No trials measured or reported the effect of testosterone on fractures. Conclusions: Intramuscular testosterone moderately increased lumbar bone density in men; the results on femoral neck bone density are inconclusive. Without bone fracture data, the available trials offer weak and indirect inferences about the clinical efficacy of testosterone on osteoporosis prevention and treatment in men.",
author = "Tracz, {Michal J.} and Kostandinos Sideras and Bolo{\~n}a, {Enrique R.} and Haddad, {Rudy M.} and Cassie Kennedy and Uraga, {Maria V.} and Caples, {Sean M.} and Erwin, {Patricia J.} and Montori, {Victor Manuel}",
year = "2006",
doi = "10.1210/jc.2006-0036",
language = "English (US)",
volume = "91",
pages = "2011--2016",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

AU - Tracz, Michal J.

AU - Sideras, Kostandinos

AU - Boloña, Enrique R.

AU - Haddad, Rudy M.

AU - Kennedy, Cassie

AU - Uraga, Maria V.

AU - Caples, Sean M.

AU - Erwin, Patricia J.

AU - Montori, Victor Manuel

PY - 2006

Y1 - 2006

N2 - Context: Androgen-deficient men are at increased risk of osteoporosis. The extent to which testosterone can prevent and treat osteoporosis in men remains unclear. Objective and Design: We performed a systematic review and meta-analysis of randomized placebo-controlled trials in men to estimate the effect of testosterone use on bone health outcomes. Data Sources: The review encompassed librarian-designed search strategies using MEDLINE (1966 to March 2005), EMBASE (1988 to March 2005), and Cochrane CENTRAL (inception to March 2005); a review of reference lists from included studies; and content expert files. Data Collection: Independently and in duplicate, we assessed the methodological quality of the eligible trials and collected data on bone mineral density and bone fractures at the longest point of complete follow-up. Data Synthesis: We included eight trials enrolling 365 patients. Two trials followed patients for more than 1 yr. Meta-analysis of these trials showed that, compared with placebo, im testosterone was associated with an 8% (95% confidence interval, 4%, 13%) gain in lumbar bone mineral density and transdermal testosterone had no significant impact. Testosterone use was associated with a nonsignificant 4% (95% confidence interval, -2%, 9%) gain in femoral neck bone mineral density with unexplained differences in results across trials (26% of these differences were not explained by chance alone). No trials measured or reported the effect of testosterone on fractures. Conclusions: Intramuscular testosterone moderately increased lumbar bone density in men; the results on femoral neck bone density are inconclusive. Without bone fracture data, the available trials offer weak and indirect inferences about the clinical efficacy of testosterone on osteoporosis prevention and treatment in men.

AB - Context: Androgen-deficient men are at increased risk of osteoporosis. The extent to which testosterone can prevent and treat osteoporosis in men remains unclear. Objective and Design: We performed a systematic review and meta-analysis of randomized placebo-controlled trials in men to estimate the effect of testosterone use on bone health outcomes. Data Sources: The review encompassed librarian-designed search strategies using MEDLINE (1966 to March 2005), EMBASE (1988 to March 2005), and Cochrane CENTRAL (inception to March 2005); a review of reference lists from included studies; and content expert files. Data Collection: Independently and in duplicate, we assessed the methodological quality of the eligible trials and collected data on bone mineral density and bone fractures at the longest point of complete follow-up. Data Synthesis: We included eight trials enrolling 365 patients. Two trials followed patients for more than 1 yr. Meta-analysis of these trials showed that, compared with placebo, im testosterone was associated with an 8% (95% confidence interval, 4%, 13%) gain in lumbar bone mineral density and transdermal testosterone had no significant impact. Testosterone use was associated with a nonsignificant 4% (95% confidence interval, -2%, 9%) gain in femoral neck bone mineral density with unexplained differences in results across trials (26% of these differences were not explained by chance alone). No trials measured or reported the effect of testosterone on fractures. Conclusions: Intramuscular testosterone moderately increased lumbar bone density in men; the results on femoral neck bone density are inconclusive. Without bone fracture data, the available trials offer weak and indirect inferences about the clinical efficacy of testosterone on osteoporosis prevention and treatment in men.

UR - http://www.scopus.com/inward/record.url?scp=33744962693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744962693&partnerID=8YFLogxK

U2 - 10.1210/jc.2006-0036

DO - 10.1210/jc.2006-0036

M3 - Article

VL - 91

SP - 2011

EP - 2016

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -